Skip to main content

$0.270 (0.00%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
24 June 2026 at 1:09pm
Register to track TDL and receive email alerts.

CE Mark Approval of SARS-CoV-2 Antigen Rapid Test

StockBot

416,823 posts

TDL released this announcement to the ASX on 11 November 2020, 8:58. The announcement is marked as price sensitive, and is 1 page(s) in length and 89.64kb in size.

You can view all announcements from TDL and see how they appear on a price chart on the announcements page.

Other Recent Announcements from TDL
Removal from Official List - Annual Listing Fees 30 August 2021, 10:24
Suspension from Official Quotation - Annual Listing Fees 23 August 2021, 10:33
Quarterly Activities/Appendix 4C Cash Flow Report 3 August 2021, 10:51
Results of Meeting 29 July 2021, 17:06
CE Mark Approval of SARS-CoV-2 Antigen Rapid Test 11 November 2020, 8:58
Quarterly Activities Report 2 November 2020, 9:54
Appendix 4C - quarterly 2 November 2020, 9:50
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track TDL and receive email alerts.